TY - JOUR
T1 - COVID-19 in Latin America and the caribbean region
T2 - Symptoms and morbidities in the epidemiology of infection
AU - Anaya-Covarrubias, Julio Y.
AU - Pizuorno, Antonio
AU - Mirazo, Santiago
AU - Torres-Flores, Jesus
AU - Du Pont, Gisela
AU - Lamoyi, Edmundo
AU - Fierro, Nora A.
N1 - Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/4
Y1 - 2022/4
N2 - The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected during the pandemic. Multiple symptoms and comorbidities are related to distinct COVID-19 outcomes. However, there has been no explanation as to why different patients present with different arrays of clinical presentations. Studies report that similar to comorbidities, each country in LA and the CA has its own particular health issues. Moreover, economic and social features have yet to be studied in detail to obtain a complete perspective of the disease in the region. Herein, the impact of demographic and economic characteristics in LA and the CA on COVID-19 are presented in combination with symptoms and comorbidities related to the disease as important aspects that can influence management and treatment.
AB - The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected during the pandemic. Multiple symptoms and comorbidities are related to distinct COVID-19 outcomes. However, there has been no explanation as to why different patients present with different arrays of clinical presentations. Studies report that similar to comorbidities, each country in LA and the CA has its own particular health issues. Moreover, economic and social features have yet to be studied in detail to obtain a complete perspective of the disease in the region. Herein, the impact of demographic and economic characteristics in LA and the CA on COVID-19 are presented in combination with symptoms and comorbidities related to the disease as important aspects that can influence management and treatment.
UR - http://www.scopus.com/inward/record.url?scp=85125669718&partnerID=8YFLogxK
U2 - 10.1016/j.coph.2022.102203
DO - 10.1016/j.coph.2022.102203
M3 - Artículo de revisión
C2 - 35255454
AN - SCOPUS:85125669718
SN - 1471-4892
VL - 63
JO - Current Opinion in Pharmacology
JF - Current Opinion in Pharmacology
M1 - 102203
ER -